AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ — RazorMetrics, a leading innovator in pharmacy cost containment technology, today announced that it generated more thanAUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ — RazorMetrics, a leading innovator in pharmacy cost containment technology, today announced that it generated more than

RazorMetrics Drives More Than $11 Million in Prescription Drug Savings for Ohio Plans and Residents

AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ — RazorMetrics, a leading innovator in pharmacy cost containment technology, today announced that it generated more than $11 million in prescription drug savings for health plans and residents across Ohio. With savings spanning nearly 60,000 covered residents, this accomplishment reflects RazorMetrics’ continued ability to reduce drug spend while supporting access to necessary medications.

Rising prescription costs remain a major pressure point for employers, health plans, and public sector programs nationwide. RazorMetrics’ solutions target avoidable pharmacy waste, including duplicative therapies, unnecessary oversupply, and opportunities to switch to clinically appropriate, lower-cost alternatives, all within prescribers’ existing workflows.

“There are clear inefficiencies in prescribing and pharmacy workflows that cause medications to be more expensive than they need to be,” said Dr. Siva Mohan, Chief Medical Officer and President of RazorMetrics. “By identifying cost-saving opportunities for physicians, we help them reduce financial burden without changing patient care.”

RazorMetrics’ platform integrates directly into clinical workflows to surface opportunities for medication switching, deprescribing, deduplication, and biosimilar use, aligned with plan design and formulary preferences. This approach helps plans achieve measurable savings while maintaining trust with providers and members.

“Ohio plans and employers are looking for solutions that deliver results without disruption,” said Tom Dorsett, CEO of RazorMetrics. “These savings show that meaningful cost reduction is possible by addressing waste inside the pharmacy benefit, rather than shifting risk or complexity onto members. After seeing strong results in Texas, Ohio was a natural next step, and we continue to evaluate where this same approach can deliver measurable savings for plans and members in other states.”

In 2025, the company reported $34 million in prescription drug savings across 1.1 million members in Texas over 24 months, demonstrating the scale of impact possible when pharmacy waste is addressed inside everyday prescribing workflows. Additionally, RazorMetrics’ active network covers more than 525,000 prescribers across the nation and Puerto Rico. Ohio’s savings outcomes extend the momentum, reinforcing that RazorMetrics’ approach consistently delivers meaningful savings across different plan types, populations, and state markets.

Building on a year of strong national momentum, RazorMetrics earned multiple recognitions for growth and innovation, including a No. 18 ranking on the Inc. 5000 and No. 12 on Deloitte’s Technology Fast 500, with top life sciences placements at both the state and national level. Entering 2026, RazorMetrics is focused on expanding its clinically aligned approach to pharmacy cost containment to help plans address both affordability and medication safety at scale.

About RazorMetrics
RazorMetrics creates cutting-edge pharmacy cost containment solutions to quickly and easily reduce drug costs. Its proprietary technology automatically initiates cost-saving opportunities through medication switching, deprescription, deduplication, and more–all while adapting to fit client’s plan, preferences, and formulary. RazorMetrics conveniently plugs into prescriber’s existing workflow, improving healthcare decisions while seamlessly reducing medication costs for members and plan sponsors. Based in Austin, TX, RazorMetrics supports self-funded employers, health plans, PBMs, and organizations to bring clarity, efficiency, and more value to their pharmacy benefits. For more information, visit www.razormetrics.com.

Media Contact
Brynn Spicher
anthonyBarnum Public Relations
brynn.spicher@anthonybarnum.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/razormetrics-drives-more-than-11-million-in-prescription-drug-savings-for-ohio-plans-and-residents-302674667.html

SOURCE RazorMetrics

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

qLabs Fires First Shot in Quantum Crypto Race — Can Coinbase Catch Up?

qLabs Fires First Shot in Quantum Crypto Race — Can Coinbase Catch Up?

The rapid progress of quantum computing is forcing the cryptocurrency industry to confront the problem that has long been treated as theoretical. Blockchains th
Share
CryptoNews2026/01/30 22:53
The Anatomy of a Self-Made Billionaire’s Mindset: How Gurhan Kiziloz Reached a $1.7B Net Worth

The Anatomy of a Self-Made Billionaire’s Mindset: How Gurhan Kiziloz Reached a $1.7B Net Worth

There are many paths to wealth in the modern economy, but the one Gurhan Kiziloz took stands out for a simple reason: he built everything himself. By 2026, the
Share
Coinstats2026/01/30 23:07
Aave DAO to Shut Down 50% of L2s While Doubling Down on GHO

Aave DAO to Shut Down 50% of L2s While Doubling Down on GHO

The post Aave DAO to Shut Down 50% of L2s While Doubling Down on GHO appeared on BitcoinEthereumNews.com. Aave DAO is gearing up for a significant overhaul by shutting down over 50% of underperforming L2 instances. It is also restructuring its governance framework and deploying over $100 million to boost GHO. This could be a pivotal moment that propels Aave back to the forefront of on-chain lending or sparks unprecedented controversy within the DeFi community. Sponsored Sponsored ACI Proposes Shutting Down 50% of L2s The “State of the Union” report by the Aave Chan Initiative (ACI) paints a candid picture. After a turbulent period in the DeFi market and internal challenges, Aave (AAVE) now leads in key metrics: TVL, revenue, market share, and borrowing volume. Aave’s annual revenue of $130 million surpasses the combined cash reserves of its competitors. Tokenomics improvements and the AAVE token buyback program have also contributed to the ecosystem’s growth. Aave global metrics. Source: Aave However, the ACI’s report also highlights several pain points. First, regarding the Layer-2 (L2) strategy. While Aave’s L2 strategy was once a key driver of success, it is no longer fit for purpose. Over half of Aave’s instances on L2s and alt-L1s are not economically viable. Based on year-to-date data, over 86.6% of Aave’s revenue comes from the mainnet, indicating that everything else is a side quest. On this basis, ACI proposes closing underperforming networks. The DAO should invest in key networks with significant differentiators. Second, ACI is pushing for a complete overhaul of the “friendly fork” framework, as most have been unimpressive regarding TVL and revenue. In some cases, attackers have exploited them to Aave’s detriment, as seen with Spark. Sponsored Sponsored “The friendly fork model had a good intention but bad execution where the DAO was too friendly towards these forks, allowing the DAO only little upside,” the report states. Third, the instance model, once a smart…
Share
BitcoinEthereumNews2025/09/18 02:28